JP2022523971A5 - - Google Patents
Info
- Publication number
- JP2022523971A5 JP2022523971A5 JP2021552602A JP2021552602A JP2022523971A5 JP 2022523971 A5 JP2022523971 A5 JP 2022523971A5 JP 2021552602 A JP2021552602 A JP 2021552602A JP 2021552602 A JP2021552602 A JP 2021552602A JP 2022523971 A5 JP2022523971 A5 JP 2022523971A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- tcr
- acid sequence
- constant region
- hla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962813645P | 2019-03-04 | 2019-03-04 | |
| US62/813,645 | 2019-03-04 | ||
| PCT/IB2020/051810 WO2020178741A1 (en) | 2019-03-04 | 2020-03-03 | T cell receptors and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523971A JP2022523971A (ja) | 2022-04-27 |
| JP2022523971A5 true JP2022523971A5 (enExample) | 2023-03-13 |
| JP7727546B2 JP7727546B2 (ja) | 2025-08-21 |
Family
ID=72336931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552602A Active JP7727546B2 (ja) | 2019-03-04 | 2020-03-03 | Ｔ細胞受容体及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12522644B2 (enExample) |
| EP (1) | EP3935176A4 (enExample) |
| JP (1) | JP7727546B2 (enExample) |
| KR (1) | KR20210149048A (enExample) |
| CN (1) | CN113795584B (enExample) |
| AU (1) | AU2020231194A1 (enExample) |
| BR (1) | BR112021017505A2 (enExample) |
| CA (1) | CA3132431A1 (enExample) |
| IL (1) | IL286046A (enExample) |
| MX (1) | MX2021010541A (enExample) |
| SG (1) | SG11202109591QA (enExample) |
| TW (1) | TW202043250A (enExample) |
| WO (1) | WO2020178741A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021010537A (es) | 2019-03-04 | 2021-12-10 | Univ Health Network | Receptores de linfocitos t y metodos de uso de estos. |
| AU2020231927A1 (en) | 2019-03-04 | 2021-09-30 | University Health Network | T cell receptors and methods of use thereof |
| US12522644B2 (en) | 2019-03-04 | 2026-01-13 | University Health Network | T cell receptors and methods of use thereof |
| AU2020231693A1 (en) | 2019-03-04 | 2021-09-30 | University Health Network | T cell receptors and methods of use thereof |
| CA3133945A1 (en) | 2019-03-25 | 2020-10-01 | University Health Network | T cell receptors and methods of use thereof |
| US20230312672A1 (en) * | 2020-06-24 | 2023-10-05 | The United States Of America,As Represented By The Secretary,Department Of Health And Human Services | Hla class i-restricted t cell receptors against cd20 |
| WO2025096983A1 (en) * | 2023-11-02 | 2025-05-08 | Board Of Regents, The University Of Texas System | Peptides and engineered t cell receptors targeting tpx2 antigen and methods of use |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2323632A1 (en) | 1998-03-13 | 1999-09-16 | Epimmune Inc. | Hla-binding peptides and their uses |
| CA2388301C (en) * | 1999-10-22 | 2011-01-04 | Aventis Pasteur Limited | Modified gp100 and uses thereof |
| US6506875B1 (en) | 2000-09-26 | 2003-01-14 | Ludwig Institute For Cancer Research | Isolated peptides which bind to HLA-C molecules and uses thereof |
| JP2008532528A (ja) | 2005-03-16 | 2008-08-21 | ディーエヌエー ジェノテック インク | 体液から得た核酸を保存するための組成物および方法 |
| CA2674445C (en) | 2007-01-12 | 2016-06-07 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Gp100-specific t cell receptors and related materials and methods of use |
| JP5292550B2 (ja) * | 2007-03-23 | 2013-09-18 | 静岡県 | Ｔ細胞レセプターβ鎖遺伝子及びα鎖遺伝子 |
| CA2682093A1 (en) | 2007-03-29 | 2008-10-09 | Technion Research & Development Foundation Ltd. | Antibodies, methods and kits for diagnosing and treating melanoma |
| EP3031916B1 (en) * | 2007-06-11 | 2017-06-07 | Takara Bio Inc. | Method for expression of specific gene |
| WO2010037395A2 (en) * | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| WO2010112962A1 (en) | 2009-04-02 | 2010-10-07 | Vaxon Biotech | Identification, optimization and use of cryptic hla-a24 epitopes for immunotherapy |
| US9314516B2 (en) | 2010-05-04 | 2016-04-19 | Cassian Yee | Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses |
| ES2635335T3 (es) | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| CN105555756B (zh) | 2013-06-28 | 2018-12-07 | 奥克兰联合服务有限公司 | 氨基酸缀合物和肽缀合物及缀合方法 |
| KR101503341B1 (ko) | 2014-03-12 | 2015-03-18 | 국립암센터 | 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법 |
| EP4270006A3 (en) * | 2014-06-13 | 2024-01-10 | Immudex ApS | General detection and isolation of specific cells by binding of labeled molecules |
| CA2964785A1 (en) | 2014-11-05 | 2016-05-12 | Board Of Regents, The University Of Texas System | Gene modified immune effector cells and engineered cells for expansion of immune effector cells |
| NL2014935B1 (en) | 2015-06-08 | 2017-02-03 | Applied Immune Tech Ltd | T cell receptor like antibodies having fine specificity. |
| JP6895975B2 (ja) | 2016-01-06 | 2021-06-30 | ヘルス リサーチ インコーポレイテッドＨｅａｌｔｈ Ｒｅｓｅａｒｃｈ， Ｉｎｃ． | 組換えｔ細胞受容体を含む組成物及びライブラリー並びに組換えｔ細胞受容体を使用する方法 |
| JP2019521080A (ja) | 2016-04-27 | 2019-07-25 | ユニバーシティ・ヘルス・ネットワーク | ペプチド−ｈｌａ複合体およびその産生方法 |
| US12522644B2 (en) | 2019-03-04 | 2026-01-13 | University Health Network | T cell receptors and methods of use thereof |
| AU2020231927A1 (en) | 2019-03-04 | 2021-09-30 | University Health Network | T cell receptors and methods of use thereof |
| BR112021017404A2 (pt) | 2019-03-04 | 2022-02-01 | Univ Health Network | Receptores de células t e métodos de uso dos mesmos |
| CA3132434A1 (en) | 2019-03-04 | 2020-09-10 | University Health Network | T cell receptors and methods of use thereof |
| AU2020231693A1 (en) | 2019-03-04 | 2021-09-30 | University Health Network | T cell receptors and methods of use thereof |
| EP3935173A4 (en) | 2019-03-04 | 2023-05-31 | University Health Network | T-CELL RECEPTORS AND METHODS OF USE THEREOF |
| MX2021010537A (es) | 2019-03-04 | 2021-12-10 | Univ Health Network | Receptores de linfocitos t y metodos de uso de estos. |
| CA3133945A1 (en) | 2019-03-25 | 2020-10-01 | University Health Network | T cell receptors and methods of use thereof |
-
2020
- 2020-03-03 US US17/436,934 patent/US12522644B2/en active Active
- 2020-03-03 AU AU2020231194A patent/AU2020231194A1/en active Pending
- 2020-03-03 KR KR1020217031557A patent/KR20210149048A/ko active Pending
- 2020-03-03 SG SG11202109591Q patent/SG11202109591QA/en unknown
- 2020-03-03 BR BR112021017505A patent/BR112021017505A2/pt not_active IP Right Cessation
- 2020-03-03 WO PCT/IB2020/051810 patent/WO2020178741A1/en not_active Ceased
- 2020-03-03 CN CN202080025149.9A patent/CN113795584B/zh active Active
- 2020-03-03 MX MX2021010541A patent/MX2021010541A/es unknown
- 2020-03-03 CA CA3132431A patent/CA3132431A1/en active Pending
- 2020-03-03 EP EP20767177.7A patent/EP3935176A4/en active Pending
- 2020-03-03 JP JP2021552602A patent/JP7727546B2/ja active Active
- 2020-03-04 TW TW109107115A patent/TW202043250A/zh unknown
-
2021
- 2021-09-01 IL IL286046A patent/IL286046A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527267A5 (enExample) | ||
| JP2022524993A5 (enExample) | ||
| JP2022523552A5 (enExample) | ||
| JP2022524994A5 (enExample) | ||
| JP2022523554A5 (enExample) | ||
| JP2022523553A5 (enExample) | ||
| JP2022524992A5 (enExample) | ||
| Baxevanis et al. | Cancer immunotherapy | |
| Batlevi et al. | Novel immunotherapies in lymphoid malignancies | |
| Kershaw et al. | Gene-engineered T cells for cancer therapy | |
| JP2022543059A5 (enExample) | ||
| US20200038443A1 (en) | Multi-function and multi-targeting car system and methods for use thereof | |
| Merhavi-Shoham et al. | Adoptive cell therapy for metastatic melanoma | |
| CN109694854B (zh) | 通用型嵌合抗原受体t细胞制备技术 | |
| JP2020509767A5 (enExample) | ||
| Tsang et al. | Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen. | |
| Shilyansky et al. | T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. | |
| Junghans | The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective | |
| Murad et al. | Advances in the use of natural receptor-or ligand-based chimeric antigen receptors (CARs) in haematologic malignancies | |
| US20170232070A1 (en) | Combination Methods for Immunotherapy | |
| JP2023512452A (ja) | Ｂｃｍａ指向性細胞免疫療法組成物および方法 | |
| CN108138148A (zh) | T细胞的激活和扩增 | |
| US11951131B2 (en) | Anti-SLAMF7 chimeric antigen receptors | |
| JP2022543060A5 (enExample) | ||
| JP2022543058A5 (enExample) |